These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23079692)

  • 1. Comparison of UVA- and UVA/riboflavin-induced growth inhibition of Acanthamoeba castellanii.
    Makdoumi K; Bäckman A; Mortensen J; Magnuson A; Crafoord S
    Graefes Arch Clin Exp Ophthalmol; 2013 Feb; 251(2):509-14. PubMed ID: 23079692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Riboflavin and ultraviolet A as adjuvant treatment against Acanthamoeba cysts.
    Lamy R; Chan E; Good SD; Cevallos V; Porco TC; Stewart JM
    Clin Exp Ophthalmol; 2016 Apr; 44(3):181-7. PubMed ID: 26355273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Riboflavin/Rose Bengal-Mediated PACK-CXL on Acanthamoeba Trophozoites and Cysts in Vitro.
    Atalay HT; Dogruman-Al F; Sarzhanov F; Özmen MC; Tefon AB; Arıbaş YK; Bilgihan K
    Curr Eye Res; 2018 Nov; 43(11):1322-1325. PubMed ID: 30021467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of in vitro efficacy of combined riboflavin and ultraviolet-A (365 nm) for Acanthamoeba].
    Letsch J; Abou-Bacar A; Candolfi E; Bourcier T; Sauer A
    J Fr Ophtalmol; 2015 Mar; 38(3):213-9. PubMed ID: 25637236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of in vitro efficacy of combined riboflavin and ultraviolet a for Acanthamoeba isolates.
    del Buey MA; Cristóbal JA; Casas P; Goñi P; Clavel A; Mínguez E; Lanchares E; García A; Calvo B
    Am J Ophthalmol; 2012 Mar; 153(3):399-404. PubMed ID: 21992713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic Resistance of Corneas Crosslinked Using Riboflavin in Conjunction With Low Energy, High Energy, and Pulsed UVA Irradiation Modes.
    Aldahlawi NH; Hayes S; O'Brart DP; Akhbanbetova A; Littlechild SL; Meek KM
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1547-52. PubMed ID: 27046119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of antibacterial efficacy of photo-activated riboflavin using ultraviolet light (UVA).
    Makdoumi K; Bäckman A; Mortensen J; Crafoord S
    Graefes Arch Clin Exp Ophthalmol; 2010 Feb; 248(2):207-12. PubMed ID: 19921518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility of photodynamic therapy (UVA/riboflavin) against Staphylococcus aureus.
    Kashiwabuchi RT; Khan Y; Carvalho FR; Hirai F; Campos MS; McDonnell PJ
    Arq Bras Oftalmol; 2012; 75(6):423-6. PubMed ID: 23715147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of photodynamic therapy with methylene blue on Acanthamoeba in vitro.
    Mito T; Suzuki T; Kobayashi T; Zheng X; Hayashi Y; Shiraishi A; Ohashi Y
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6305-13. PubMed ID: 22918636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First proposed efficacy study of high versus standard irradiance and fractionated riboflavin/ultraviolet a cross-linking with equivalent energy exposure.
    Krueger RR; Herekar S; Spoerl E
    Eye Contact Lens; 2014 Nov; 40(6):353-7. PubMed ID: 25365552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic UVA-riboflavin bacterial elimination in antibiotic-resistant bacteria.
    Makdoumi K; Bäckman A
    Clin Exp Ophthalmol; 2016 Sep; 44(7):582-586. PubMed ID: 26867998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The comparative safety of genipin versus UVA-riboflavin crosslinking of rabbit corneas.
    Song W; Tang Y; Qiao J; Li H; Rong B; Yang S; Wu Y; Yan X
    Mol Vis; 2017; 23():504-513. PubMed ID: 28761323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the direct application of riboflavin and UVA on the Visian Implantable Collamer Lens.
    Hafezi F; Majo F; El Danasoury AM
    J Refract Surg; 2010 Oct; 26(10):762-5. PubMed ID: 20481415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of ultraviolet A-induced crosslinking on dentin collagen matrix.
    Seseogullari-Dirihan R; Tjäderhane L; Pashley DH; Tezvergil-Mutluay A
    Dent Mater; 2015 Oct; 31(10):1225-31. PubMed ID: 26314255
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Sharma A; Sharma R; Chander J; Nirankari VS
    Taiwan J Ophthalmol; 2023; 13(1):21-27. PubMed ID: 37252159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Keratocyte cytotoxicity of riboflavin/UVA-treatment in vitro.
    Wollensak G; Spoerl E; Reber F; Seiler T
    Eye (Lond); 2004 Jul; 18(7):718-22. PubMed ID: 14739922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photoinactivation of the bacteriophage PhiX174 by UVA radiation and visible light in SM buffer and DMEM-F12.
    Sommerfeld F; Weyersberg L; Vatter P; Hessling M
    BMC Res Notes; 2024 Jan; 17(1):3. PubMed ID: 38167092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Keratocyte apoptosis after corneal collagen cross-linking using riboflavin/UVA treatment.
    Wollensak G; Spoerl E; Wilsch M; Seiler T
    Cornea; 2004 Jan; 23(1):43-9. PubMed ID: 14701957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Riboflavin Plays a Pivotal Role in the UVA-Induced Cytotoxicity of Fibroblasts as a Key Molecule in the Production of H
    Yoshimoto S; Kohara N; Sato N; Ando H; Ichihashi M
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31952279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficiency of cross-linking methods in eradication of bacteria is influenced by the riboflavin concentration and the irradiation time of ultraviolet light.
    Bäckman A; Makdoumi K; Mortensen J; Crafoord S
    Acta Ophthalmol; 2014 Nov; 92(7):656-61. PubMed ID: 25493311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.